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Abstract
Radiotherapy is one of the main ways head and neck cancers are treated;
radiation is used to kill cancerous cells and prevent their recurrence.
 
Complex treatment planning is required to ensure that enough radiation is given
to the tumour, and little to other sensitive structures (known as organs at risk)
such as the eyes and nerves which might otherwise be damaged. This is
especially difficult in the head and neck, where multiple at-risk structures often
lie in extremely close proximity to the tumour. It can take radiotherapy experts
four hours or more to pick out the important areas on planning scans (known as
segmentation).
 
This research will focus on applying machine learning algorithms to automatic
segmentation of head and neck planning computed tomography (CT) and
magnetic resonance imaging (MRI) scans at University College London
Hospital NHS Foundation Trust patients. Through analysis of the images used
in radiotherapy DeepMind Health will investigate improvements in efficiency of
cancer treatment pathways.
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Background
Cancers of the head and neck account for 2% of all cancers, and 
worldwide they account for around 300,000 deaths each year. 
Between 1990 and 2006 the incidence of different head and neck 
cancers has altered dramatically. The incidence of oral cavity 
cancer has risen by more than 30% to 3.02 per 100,000 and 
oropharyngeal cancer incidence has more than doubled with a 
significant change in causation (human papilloma virus rather 
than smoking or alcohol) and at-risk subpopulation (younger 
rather than older patients) (NCIN, 2012; OCIU, 2010; Parkin, 
2010).
Most such cancers are treated using radiotherapy (CRUK, 2016). 
Planning such treatment involves delineating the tumour to be 
irradiated, and also the structures (organs at risk, OAR) to which 
administration of radiation should be minimised. The complex 
anatomy of the head and neck, where multiple OARs often lie in 
extremely close proximity to the tumour, make this process (known 
as ‘segmentation’) difficult: it can take radiotherapy experts four 
hours or more to do this (Harari et al., 2010). Furthermore as 
tumour and body shape change over a course of treatment (which 
can last weeks), it can be necessary to repeat the segmentation 
analysis at both fiscal and temporal cost; longer times between 
cancer diagnosis and treatment increase mortality and worsen 
outcomes (Chen et al., 2008; Mikeljevic et al., 2004).
Advances in machine learning have allowed the creation of 
sophisticated image recognition tools which might perform this 
process faster and at least as accurately. Machine learning has 
undergone a revolutionary transformation with the resounding suc-
cess of so-called Deep Learning algorithms introduced by (Hinton 
et al., 2006) and demonstrated at scale by others (Krizhevsky et al., 
2012). Those algorithms combine artificial neural networks, well-
known since their introduction in the mid-50s (Rosenblatt, 1959), 
with advances in computational power and algorithmics which 
have enabled remarkable success in handling the deluge of high- 
dimensional “big data” (Krizhevsky et al., 2012). This resulted 
in the development and rapid deployment of automatic feature 
extraction, i.e. combining parts of the data into meaningful 
elementary units for higher-level processing, that would have 
previously required the painstaking trial-and-error process of 
manual design by a human.
Such processes might be readily applied to automated 
segmentation for radiotherapy planning in the treatment of 
head and neck tumours. The prevalence of head and neck can-
cers, and the complexity of radiotherapy planning, make them 
ideal targets for such an automated computer-based approach. 
An automated segmentation system would allow planning to 
start immediately after a patient is scanned. Such a service could 
increase speed to treatment. It could also help reduce varia-
tion in radiotherapy outcomes between centres (Peters et al., 
2010) by standardising planning prior to dose simulation while 
increasing the efficiency of patient workflow. Although many 
techniques have been proposed for automatic segmentation in 
radiotherapy (Daisne & Blumhofer, 2013; Rohlfing et al., 2005), 
none have shown sufficiently good performance for routine use in 
clinical care.
In order for machine learning algorithms to reach expert levels at 
image segmentation, they must first learn from existing data. This 
study aims to achieve this with a dataset of expertly labelled images 
from previously-treated patients at University College London 
Hospital (UCLH) NHS Foundation Trust (London, UK), with the 
ultimate objective of improving outcomes for patients with head 
and neck cancers.
Aims and objectives
Primary objective
1.1
To investigate the feasibility of developing computer algorithms 
that can identify important anatomical structures and the cancers 
themselves in head and neck cancer planning scans to help target 
radiotherapy treatment.
Secondary objectives
Should the primary objective be accomplished, we intend to 
validate performance using retrospective data through: 
2.1
Assessment of quality of automated segmentation using retrospec-
tive planning CT images. Expert radiation oncologists, blind to 
image source, will assess both automatically and manually seg-
mented scans, and determine whether segmentation met a standard 
for clinical use.
Study design
This is a retrospective, non-interventional study. Analyses 
performed in the study will be on fully anonymised medical images 
(computed tomography (CT) and magnetic resonance imaging 
(MRI) scans, labelled with manual segmentation, dose threshold 
and cancer type).
The protocol follows similar procedures to De Fauw et al. (2016). 
Inclusion criteria
Patients who received radiotherapy treatment for head and neck 
cancers at UCLH NHS Foundation Trust between 01/01/2008 and 
20/03/2016 will be eligible for inclusion in this study.
Exclusion criteria
Data from patients who have previously manually requested that 
that their data should not be shared, even for research purposes in 
anonymised form, and have informed the UCLH NHS Foundation 
Trust of this, will be ineligible and removed by UCLH NHS 
Foundation Trust staff before research begins.
Sample size
Approximately 700 retrospective patient cases will be part of this 
study.
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Most recent machine learning algorithms benefit from large 
datasets on which to train (tens to hundreds of thousands of 
data instances (Silver et al., 2016)). Across all machine learning 
applications the predictive power (as percentage of data instances 
correctly classified) of the algorithm depends on the size and qual-
ity of the dataset.
The sample size is informed by the existing literature (Mnih, 
2015; Silver et al., 2016) and by DeepMinds previous work in the 
field of machine learning. We believe that the research goals are 
possible despite the relatively small number of scans, as compared 
to other research projects because of low variation between the 
different biological images and by limiting the scope of the research 
to segmentation rather than diagnosis.
Data
For all patients meeting inclusion/exclusion criteria the following 
electronic health record data will be required to complete this 
project successfully: 
(1)  CT scan(s) taken during the course of radiotherapy 
planning and treatment
(2)  MRI scan(s) taken during the course of radiotherapy 
planning and treatment
(3)  CT labelling information outlining anatomical and tumour 
volumes, with associated radiotherapy dose thresholds
(4)  Information on what type of tumour is present in each 
image
(5) Patient gender and age group (to the nearest 5 years)
The anonymisation procedures adopted will remove any informa-
tion not specified to further avoid transfer of patient identifiable 
information. All anonymisation will be formally verified by UCLH 
NHS Foundation Trust staff before transfer.
Algorithm development
In order to develop the algorithms, DeepMind will work with 
the labelled medical image files to apply machine learning and 
AI techniques including but not limited to: supervised and semi-
supervised convolutional neural networks, recurrent neural net-
works, unsupervised clustering, reinforcement learning (Murphy, 
2012).
Statistical analysis
Descriptive statistics (such as the Dice similarity coefficient, 
average surface distance and maximal surface distance) will be 
used to compare the quality of algorithm segmentation against the 
expert reference segmentation during algorithm training.
In order to assess the accuracy of the final model segmentation 
a retrospective test subset of radiotherapy planning images will 
also have both manual and automatic segmentations corrected by 
expert clinicians who have not seen the images before and who are 
blinded to how the segmentation was produced. The same statistical 
methods described above will be used to compare the ground truth 
manual segmentation, automatic segmentation and clinically 
corrected manual and automatic segmentations.
Data protection
Anonymisation
This study requires existing retrospective data only; no prospective 
data are needed nor will be collected from patients, hospitals or 
healthcare workers. No direct patient contact will occur and neces-
sary data will be anonymised from this source dataset.
Anonymisation of all image files and clinical information is per-
formed and validated at UCLH NHS Foundation Trust before 
transfer. No patient identifiers will be transferred to DeepMind. 
In addition the data will be protected to HSCIC Information 
Governance standards and access is strictly controlled to prevent 
any attempt to re-identify the data.
Data storage
DeepMind Health has developed and established a state-of-the-art 
secure patient information handling service utilising Common 
Criteria EAL4 compliant firewalls and on-disk encryption (using 
Advanced Encryption Standard with a 256-bit key) of all research 
data, all housed within an ISO 27001 compliant data centre. After 
anonymisation data will be transferred to our London, UK data 
centre. This data handling facility conforms to NHS HSCIC Infor-
mation Governance Statement of Compliance Toolkit (formally 
assessed at level 3).
Access will be granted by the custodian of data and no other 
members of the team. Only those working directly on the data in 
a research capacity will have access.
Data destruction
The data sharing agreement between DeepMind and UCLH 
NHS Foundation Trust lasts for 5 years. After this period the 
agreement will be reviewed should future work seek to build on 
this project. After the data sharing agreement expires all data 
used in the study will be destroyed. No modification will be made 
based on the data after destruction.
Data destruction will involve the deletion of the encryption/ 
decryption keys for all project volumes, and 8-pass random data 
write to all physical disks within the DeepMind Health data infra-
structure. A certificate of destruction will be provided to the Trust.
The algorithms developed during the study will not be destroyed. 
DeepMind Health knows of no way to recreate the patient 
images transferred from the algorithms developed. No patient 
identifiable data will be included in the algorithms.
Ethical considerations
Ethical approvals
The research on the dataset received formal Research Ethics 
Committee approval on 6th April 2016 (REC reference 
16/SC/0189).
Consent
No patient will be approached directly. Only anonymised 
retrospective data collected as part of routine clinical care are 
included. In such cases the ICO code of practice states that explicit 
consent is not generally required (ICO, 2012). 
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Adverse events
The project is non-interventional and does not involve any direct 
patient contact. All patient data is historical and all patients have 
completed their radiotherapy treatment prior to data transfer.
Monitoring
The study will be monitored both internally and externally. 
Internally DeepMind managers (TB, JL) will oversee and monitor 
progress on a day-to-day basis, ensuring the protocol is adhered to 
and no compliance issues arise.
Clinical and methodological experts (RM, DD, KS, SAM, GR, RR) 
are working with DeepMind to further oversee the ethical, clinical 
and methodological considerations of the project and will advise 
on at least a weekly basis to ensure no deviation from the described 
protocol.
Externally the information governance team at the UCLH NHS 
Foundation Trust will be consulted before commencing data 
collection.
Access
DeepMind has access to the required data to support the 
research aims of this study. To ensure compliance with the 
common law principle of data confidentiality, DeepMind will 
only receive anonymised data from UCLH NHS Foundation 
Trust. DeepMind works with the Trust to ensure accuracy and 
clarity in the data to allow useful and consistent interpretation at 
all times.
Dissemination
The results will be disseminated through normal academic 
channels, initially focusing on conference proceedings and the 
indexed peer reviewed literature relevant to the fields of machine 
learning, artificial intelligence, radiotherapy and clinical research. 
DeepMind will engage in patient and public involvement groups 
during the research study.
Conclusion
We propose an exploratory study covers an initial testing of 
machine learning algorithms for automatic segmentation of head 
and neck planning CT and MRI scans. The results will be assessed 
against expert segmentation.
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This study protocol presented the procedure to acquire and analyse medical image data for automatic
segmentation. The protocol is clear besides the following points need to be clarified:
The authors presented the algorithm used for segmentation very briefly. This part should be
elaborated to inform the details of each algorithm used. Also, citation of Murphy 2012 was not
found in the reference.
 
The statistical analysis was not well presented. The evaluation and statistical methods should be
described in detail.
 
There are many different segmentation studies in the literature, some specifically aimed for
radiotherapy should be cited.
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